← back to search

Christopher P. Filson

Emory Healthcare · US
Area of research
Pulmonary and Respiratory Medicine · Surgery
Research interest
Research interests include Prostate Cancer Diagnosis and Treatment, Prostate Cancer Treatment and Research, Bladder and Urothelial Cancer Treatments, and Renal cell carcinoma treatment.
h-index
22
citations
2,260
works
190
NIH funding
primary concept
email

Recent publications

Neoadjuvant cabozantinib for locally advanced nonmetastatic clear cell renal cell carcinoma: a phase 2 trial
Nature Cancer 2025cited by 11position: middledoi
Prostate zonal impact of 5α‐reductase inhibitors on multiparametric <scp>MRI</scp> characteristics and detection of prostate cancer
British Journal of Urology 2025cited by 2position: middledoi
Long-Term Outcomes in Patients Using Protocol-Directed Active Surveillance for Prostate Cancer
JAMA 2024cited by 62position: middledoi
Proposal for an optimised definition of adverse pathology (unfavourable histology) that predicts metastatic risk in prostatic adenocarcinoma independent of grade group and pathological stage
Histopathology 2024cited by 26position: middledoi
Disparities in time to prostate cancer treatment initiation before and after the Affordable Care Act
Cancer Medicine 2023cited by 12position: middledoi
Multi‐institutional analysis of clinical and imaging risk factors for detecting clinically significant prostate cancer in men with <scp>PI‐RADS</scp> 3 lesions
Cancer 2022cited by 40position: middledoi
Longitudinal impact of bladder cancer diagnosis on common psychiatric disorders
Cancer Medicine 2021cited by 13position: middledoi
Trends in the use of active surveillance and treatments in Medicare beneficiaries diagnosed with localized prostate cancer
Urologic Oncology Seminars and Original Investigations 2020cited by 36position: middledoi
Magnetic Resonance Imaging for the Detection of High Grade Cancer in the Canary Prostate Active Surveillance Study
The Journal of Urology 2020cited by 30position: middledoi
An intra-tumoral niche maintains and differentiates stem-like CD8 T cells
Nature 2019cited by 830position: middledoi
African American Race is Not Associated with Risk of Reclassification during Active Surveillance: Results from the Canary Prostate Cancer Active Surveillance Study
The Journal of Urology 2019cited by 37position: middledoi
Adherence to Active Surveillance Protocols for Low-risk Prostate Cancer: Results of the Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance Initiative
European Urology Oncology 2019cited by 37position: middledoi
Increasing Utilization of Multiparametric Magnetic Resonance Imaging in Prostate Cancer Active Surveillance
Urology 2019cited by 36position: middledoi
Reasons for Discontinuing Active Surveillance: Assessment of 21 Centres in 12 Countries in the Movember GAP3 Consortium
European Urology 2018cited by 92position: middledoi
Comparison of Outcomes in Patients With Muscle-invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder Preservation
American Journal of Clinical Oncology 2018cited by 62position: middledoi
Adoption of Prebiopsy Magnetic Resonance Imaging for Men Undergoing Prostate Biopsy in the United States
Urology 2018cited by 53position: lastdoi
Evaluating Clinical Implementation Approaches for Prostate Cancer Decision Support
Urology Practice 2018cited by 22position: middledoi
Patient Frailty and Discharge Disposition Following Radical Cystectomy
Clinical Genitourinary Cancer 2017cited by 57position: middledoi
Decision Support with the Personal Patient Profile-Prostate: A Multicenter Randomized Trial
The Journal of Urology 2017cited by 47position: middledoi
Comparative Cost Analysis: Teleurology vs Conventional Face-to-Face Clinics
Urology 2017cited by 45position: middledoi
Surgical Margins in Nephron-Sparing Surgery for Renal Cell Carcinoma
Current Urology Reports 2017cited by 44position: middledoi
Prostate cancer detection with magnetic resonance‐ultrasound fusion biopsy: The role of systematic and targeted biopsies
Cancer 2016cited by 407position: firstdoi
Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008
Cancer 2016cited by 345position: middledoi
The Relationship between Intolerance of Uncertainty and Anxiety in Men on Active Surveillance for Prostate Cancer
The Journal of Urology 2016cited by 76position: middledoi
Implementation of a Tele-urology Program for Outpatient Hematuria Referrals: Initial Results and Patient Satisfaction
Urology 2016cited by 46position: middledoi
Urologist Use of Cystoscopy for Patients Presenting With Hematuria in the United States
Urology 2016cited by 40position: lastdoi
Expectant management for men with early stage prostate cancer
CA A Cancer Journal for Clinicians 2015cited by 70position: firstdoi
Technique and Outcomes of Robot-assisted Retroperitoneoscopic Partial Nephrectomy: A Multicenter Study
European Urology 2014cited by 84position: middledoi
Variation in Use of Active Surveillance among Men Undergoing Expectant Treatment for Early Stage Prostate Cancer
The Journal of Urology 2014cited by 68position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Viraj A. Master · Emory University7 papers (2016–2021)James D. Brooks · Intel (United States)4 papers (2019–2024)Dattatraya Patil · Emory University4 papers (2016–2021)Peter S. Nelson · Bloodworks Northwest4 papers (2019–2024)Lisa F. Newcomb · University of Michigan–Ann Arbor4 papers (2019–2024)Mark S. Litwin · University of California, Los Angeles3 papers (2015–2016)Todd M. Morgan · Southwestern Medical Center3 papers (2019–2024) · 3 papers (2019–2024)Michael A. Liss · Royal Adelaide Hospital3 papers (2019–2024)Peter R. Carroll · UCSF Helen Diller Family Comprehensive Cancer Center3 papers (2019–2024)Martin Gleave · Prostate Cancer Canada3 papers (2019–2024)Matthew R. Cooperberg · UCSF Helen Diller Family Comprehensive Cancer Center3 papers (2019–2024)Martin G. Sanda · Emory University3 papers (2017–2018)Leonard S. Marks · University of California, Los Angeles3 papers (2015–2016)Muta M. Issa · Emory University3 papers (2016–2017)Mehrdad Alemozaffar · Emory University Hospital3 papers (2016–2018)Yingye Zheng · Seattle University3 papers (2019–2024)Ian M. Thompson · Campbell Center for Historic Preservation Studies2 papers (2019–2020)Jeffrey Pearl · Career Education Corporation2 papers (2016–2017)Gary W. Chien · Brown University2 papers (2017–2018)